Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2275
Nomenclature: VRK serine/threonine kinase 1
Abbreviated Name: VRK1
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 396 | 14q32.2 | VRK1 | VRK serine/threonine kinase 1 | |
Mouse | - | 440 | 12 E-F1 | Vrk1 | vaccinia related kinase 1 | |
Rat | - | 414 | 6 q32 | Vrk1 | VRK serine/threonine kinase 1 |
Database Links | |
Alphafold | Q99986 (Hs), Q80X41 (Mm) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL1293199 (Hs) |
Ensembl Gene | ENSG00000100749 (Hs), ENSMUSG00000021115 (Mm), ENSRNOG00000005274 (Rn) |
Entrez Gene | 7443 (Hs), 22367 (Mm), 362779 (Rn) |
Human Protein Atlas | ENSG00000100749 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:7443 (Hs), mmu:22367 (Mm), rno:362779 (Rn) |
OMIM | 602168 (Hs) |
Orphanet | ORPHA208345 (Hs) |
Pharos | Q99986 (Hs) |
RefSeq Nucleotide | NM_003384 (Hs), NM_001029843 (Mm), NM_001012194 (Rn) |
RefSeq Protein | NP_003375 (Hs), NP_001025014 (Mm), NP_001012194 (Rn) |
UniProtKB | Q99986 (Hs), Q80X41 (Mm) |
Wikipedia | VRK1 (Hs) |
Selected 3D Structures | |||||||||||
|
Enzyme Reaction | ||||
|
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service. A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform. http://www.millipore.com/techpublications/tech1/pf3036 http://www.reactionbiology.com/webapps/main/pages/kinase.aspx Reference: ...1 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: nd/VRK1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||
|
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Shin J, Chakraborty G, Bharatham N, Kang C, Tochio N, Koshiba S, Kigawa T, Kim W, Kim KT, Yoon HS. (2011) NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity. J Biol Chem, 286 (25): 22131-8. [PMID:21543316]
Vaccina related kinase (VRK) family: VRK serine/threonine kinase 1. Last modified on 18/09/2018. Accessed on 20/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2275.